ArticleJournal of market access & health policy2021

Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia.

Anuraag R Kansal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.